Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Abemaciclib (Primary)
- Indications Carcinoma; Early breast cancer
- Focus Therapeutic Use
- Acronyms ABC-POP
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress
- 27 Mar 2018 Status changed from recruiting to completed.
- 07 Aug 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.